The 20 references in paper A. Chukhlovin B., N. Kuzubova A., N. Elshin D., O. Titova N., А. Чухловин Б., Н. Кузубова А., Н. Елшин Д., О. Титова Н. (2015) “Экспрессия генов ADRB2 и CHRM3 в лейкоцитах крови у больных с обострением хронической обструктивной болезни легких // ADRB2 and CHRM3 gene expression in blood leukocytes of patients with acute exacerbation of chronic obstructive pulmonary disease” / spz:neicon:pulmonology:y:2015:i:2:p:151-156

1
Чучалин А.Г., Айсанов З.Р., Авдеев С.Н. и др. Федеральные клинические рекомендации по диагностике и лечению хронической обструктивной болезни легких. М.: Российское респираторное общество; 2013.
(check this in PDF content)
2
Dale Ph.R., Cernecka H., Schmidt M. et al. The pharmacological rationale for combining muscarinic receptor 154Пульмонология. 2015; 25 (2): 151–156 antagonists and β-adrenoceptor agonists in the treatment of airway and bladder disease. Curr. Opin. Pharmacol. 2014; 16: 31–42.
(check this in PDF content)
3
Огородова Л.М., Черняк Б.А., Козина О.В. и др. Молекулярно-генетические аспекты различных фенотипов хронической обструктивной болезни легких и бронхиальной астмы. Пульмонология. 2013; 1: 5–11.
(check this in PDF content)
4
Kin N.W., Sanders V.M. It takes nerve to tell T and B cells what to do. J. Leukoc. Biol.2006; 79 (6): 1093–1104.
(check this in PDF content)
5
Yu X.Y., Lin S.G., Wang X.M. et al. Evidence for coexistence of three β-adrenoceptor subtypes in human peripheral lymphocytes. Clin. Pharmacol. Ther. 2007; 81 (5): 654–658.
(check this in PDF content)
6
Fujii T., Takada-Takatori Y., Kawashima K. Basic and clinical aspects of non-neuronal acetylcholine: expression of an independent, non-neuronal cholinergic system in lymphocytes and its clinical significance in immunotherapy. J. Pharmacol. Sci.2008; 106 (2): 186–192.
(check this in PDF content)
7
Клемент Р.Ф., Лаврушин А.А., Тер-Погосян П.А. Инструкция по применению формул и таблиц должных величин основных спирографических показателей. Л.; 1986.
(check this in PDF content)
8
Moniotte S., Vaerman J.L., Kockx M.M. et al. Real-time RT-PCR for the detection of beta-adrenoceptor messenger RNAs in small human endomyocardial biopsies. J. Mol. Cell. Cardiol. 2001; 33 (12): 2121–2133.
(check this in PDF content)
9
Patel N., Itakura T., Gonzalez J.M. Jr et al. GPR158, an orphan member of G protein-coupled receptor family C: glucocorticoid-stimulated expression and novel nuclear role.PLoS One. 2013; 8 (2): e57843. DOI: 10.1371/journal.pone.0057843.
(check this in PDF content)
10
Braden G.L., Germain M.J., Mulhern J.G. et al. Hemodynamic, cardiac, and electrolyte effects of low-dose aerosolized terbutaline sulfate in asthmatic patients. Chest. 1998; 114 (2): 380–387.
(check this in PDF content)
11
Bjermer L., Bengtsson Th., Jorup C. et al. Local and systemic effects of inhaled AZD9164 compared with tiotropium in patients with COPD. Respir. Med.2013; 107 (1): 84–90.
(check this in PDF content)
12
Theron A.J., Steel H.C., Tintinger G.R. et al. Can the anti-inflammatory activities of β2-agonists be harnessed in the clinical setting? Drug Des. Devel. Ther.2013; 7: 1387–1398.
(check this in PDF content)
13
Black J.L., Oliver B.G.G., Roth M. Molecular mechanisms of combination therapy with inhaled corticosteroids and long-acting β-agonists. Chest. 2009; 136 (4): 1095–1100.
(check this in PDF content)
14
Dalby Ch., Polanowski T., Larsson Th. et al. The bioavailability and airway clearance of the steroid component of budesonide / formoterol and salmeterol / fluticasone after inhaled administration in patients with COPD and healthy subjects: a randomized controlled trial. Respir. Res.2009; 10: 104. DOI: 10.1186/1465-9921-10-104.
(check this in PDF content)
15
Rüdiger J.J., Gencay M., Yang J.Q. et al. Fast beneficial systemic anti-inflammatory effects of inhaled budesonide and formoterol on circulating lymphocytes in asthma. Respirology. 2013; 18 (5): 840–847.
(check this in PDF content)
16
Barnes P.J. Scientific rationale for inhaled combination therapy with long-acting β2-agonists and corticosteroids. Eur. Respir. J.2002; 19 (1): 182–191.
(check this in PDF content)
17
Oakley R.H., Cidlowski J.A. The biology of the glucocorticoid receptor: new signaling mechanisms in health and disease. J. Allergy Clin. Immunol.2013; 132 (5): 1033–1044.
(check this in PDF content)
18
Selivanova P.A., Kulikov E.S., Kozina O.V. et al. Differential expression of the β2-adrenoreceptor and M3-cholinoreceptor genes in bronchial mucosa of patients with asthma and chronic obstructive pulmonary disease. Ann. Allergy Asthma Immunol. 2012; 108 (1): 39–43.
(check this in PDF content)
19
Kerstjens H.A.M., Engel M., Dahl R. et al. Tiotropium in asthma poorly controlled with standard combination therapy. N. Engl. J. Med.2012; 367 (13): 1198–1207.
(check this in PDF content)
20
Gosens R., Zaagsma J., Meurs H. et al. Muscarinic receptor signaling in the pathophysiology of asthma and COPD. Respir. Res.2006; 7: 73. Поступила 05.02.15 УДК 616.24+036.12+07:616.155.392+
(check this in PDF content)